140 related articles for article (PubMed ID: 33631040)
1. Delay to surgery after neoadjuvant chemotherapy in head and neck squamous cell carcinoma affects oncologic outcomes.
Kiong KL; Yao CMKL; Lin FY; Bell D; Ferrarotto R; Weber RS; Lewis CM
Cancer; 2021 Jun; 127(12):1984-1992. PubMed ID: 33631040
[TBL] [Abstract][Full Text] [Related]
2. Multifocal regression and pathologic response predicts recurrence after neoadjuvant chemotherapy in head and neck squamous cell carcinoma.
Kiong KL; Bell D; Yao CM; Ferrarotto R; Lewis CM
Oral Oncol; 2021 Nov; 122():105520. PubMed ID: 34521029
[TBL] [Abstract][Full Text] [Related]
3. Time to surgery following neoadjuvant chemotherapy for breast cancer impacts residual cancer burden, recurrence, and survival.
Sutton TL; Schlitt A; Gardiner SK; Johnson N; Garreau JR
J Surg Oncol; 2020 Dec; 122(8):1761-1769. PubMed ID: 33125715
[TBL] [Abstract][Full Text] [Related]
4. Salvage Surgery for Recurrence after Radiotherapy for Squamous Cell Carcinoma of the Head and Neck.
Elbers JBW; Al-Mamgani A; van den Brekel MWM; Jóźwiak K; de Boer JP; Lohuis PJFM; Willems SM; Verheij M; Zuur CL
Otolaryngol Head Neck Surg; 2019 Jun; 160(6):1023-1033. PubMed ID: 30526317
[TBL] [Abstract][Full Text] [Related]
5. Predictive factors for long-term survival in head and neck squamous cell carcinoma patients with distant metastasis after initial definitive treatment.
Kang HS; Roh JL; Kim MJ; Cho KJ; Lee SW; Kim SB; Choi SH; Nam SY; Kim SY
J Cancer Res Clin Oncol; 2016 Jan; 142(1):295-304. PubMed ID: 26341665
[TBL] [Abstract][Full Text] [Related]
6. Relevance of the time interval between surgery and adjuvant radio (chemo) therapy in HPV-negative and advanced head and neck carcinoma of unknown primary (CUP).
Balk M; Rupp R; Mantsopoulos K; Allner M; Grundtner P; Mueller SK; Traxdorf M; Eckstein M; Speer S; Semrau S; Fietkau R; Iro H; Hecht M; Gostian AO
BMC Cancer; 2021 Nov; 21(1):1236. PubMed ID: 34794411
[TBL] [Abstract][Full Text] [Related]
7. Impact of neoadjuvant chemotherapy on perioperative morbidity after major surgery for head and neck cancer.
Kiong KL; Lin FY; Yao CMKL; Guo T; Ferrarotto R; Weber RS; Lewis CM
Cancer; 2020 Oct; 126(19):4304-4314. PubMed ID: 32706401
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of Interval Between the Initiation of Neoadjuvant Treatment to Surgery for Patients With Locally Advanced Rectal Cancer Following Neoadjuvant Chemotherapy, Radiotherapy and Definitive Surgery.
Wan XB; Zhang Q; Chen M; Liu Y; Zheng J; Lan P; He F
Front Oncol; 2020; 10():1280. PubMed ID: 32974129
[No Abstract] [Full Text] [Related]
9. Nodal Metastasis Count and Oncologic Outcomes in Head and Neck Cancer: A Secondary Analysis of NRG/RTOG 9501, NRG/RTOG 0234, and EORTC 22931.
Lu DJ; Luu M; Gay C; Nguyen AT; Anderson EM; Bernier J; Cooper JS; Harari PM; Torres-Saavedra PA; Le QT; Chen MM; Clair JM; Ho AS; Zumsteg ZS
Int J Radiat Oncol Biol Phys; 2022 Jul; 113(4):787-795. PubMed ID: 35395358
[TBL] [Abstract][Full Text] [Related]
10. Patterns of Recurrence and Predictors of Survival in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy, Surgery, and Radiation.
Keilty D; Nezafat Namini S; Swain M; Maganti M; Cil TD; McCready DR; Cescon DW; Amir E; Fleming R; Mulligan AM; Fyles A; Croke JM; Liu FF; Levin W; Koch CA; Han K
Int J Radiat Oncol Biol Phys; 2020 Nov; 108(3):676-685. PubMed ID: 32407932
[TBL] [Abstract][Full Text] [Related]
11. High-risk pathological features at the time of salvage surgery predict poor survival after definitive therapy in patients with head and neck squamous cell carcinoma.
Haque S; Karivedu V; Riaz MK; Choi D; Roof L; Hassan SZ; Zhu Z; Jandarov R; Takiar V; Tang A; Wise-Draper T
Oral Oncol; 2019 Jan; 88():9-15. PubMed ID: 30616803
[TBL] [Abstract][Full Text] [Related]
12. Salvage surgery in recurrent head and neck squamous cell carcinoma: Oncologic outcome and predictors of disease free survival.
Hamoir M; Holvoet E; Ambroise J; Lengelé B; Schmitz S
Oral Oncol; 2017 Apr; 67():1-9. PubMed ID: 28351561
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant chemotherapy with S-1 after curative chemoradiotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neck: Reanalysis of the ACTS-HNC study.
Kubota A; Nakatani E; Tsukahara K; Hasegawa Y; Takemura H; Terada T; Taguchi T; Nagahara K; Nakatani H; Yoshino K; Higaki Y; Iwae S; Beppu T; Hanamure Y; Tomita K; Kohno N; Kawabata K; Teramukai S; Fujii M;
PLoS One; 2018; 13(6):e0198391. PubMed ID: 29883463
[TBL] [Abstract][Full Text] [Related]
14. Influence of pathologic complete response to neoadjuvant chemotherapy on long-term survival of patients with advanced head and neck squamous cell carcinoma.
Zhang XR; Liu ZM; Liu XK; Wang FH; Li Q; Li H; Li QL; Guo ZM; Zeng ZY
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Feb; 115(2):218-23. PubMed ID: 23265986
[TBL] [Abstract][Full Text] [Related]
15. Time to Surgery and Survival in Head and Neck Cancer.
Rygalski CJ; Zhao S; Eskander A; Zhan KY; Mroz EA; Brock G; Silverman DA; Blakaj D; Bonomi MR; Carrau RL; Old MO; Rocco JW; Seim NB; Puram SV; Kang SY
Ann Surg Oncol; 2021 Feb; 28(2):877-885. PubMed ID: 33188461
[TBL] [Abstract][Full Text] [Related]
16. Incurable locoregional disease is a strong poor prognostic factor in recurrent or metastatic squamous cell carcinoma of the head and neck.
Nishimura A; Yokota T; Hamauchi S; Onozawa Y; Shirasu H; Kawabata T; Ogawa H; Onoe T; Iida Y; Mukaigawa T; Yasui H
Int J Clin Oncol; 2021 Oct; 26(10):1822-1830. PubMed ID: 34152533
[TBL] [Abstract][Full Text] [Related]
17. Treatment Outcome in Head and Neck Cancer With Distant Metastasis at Initial Diagnosis.
Omata J; Ueki Y; Takahashi Y; Tanaka R; Yokoyama Y; Takahashi T; Shodo R; Yamazaki K; Togashi T; Matsuyama H; Takahashi N; Okabe R; Horii A
Laryngoscope; 2024 Apr; 134(4):1679-1686. PubMed ID: 37698411
[TBL] [Abstract][Full Text] [Related]
18. Correlation of gene methylation in surgical margin imprints with locoregional recurrence in head and neck squamous cell carcinoma.
Hayashi M; Wu G; Roh JL; Chang X; Li X; Ahn J; Goldsmith M; Khan Z; Bishop J; Zhang Z; Zhou XC; Richmon J; Agrawal N; Koch WM
Cancer; 2015 Jun; 121(12):1957-65. PubMed ID: 25773145
[TBL] [Abstract][Full Text] [Related]
19. A pre-operative prognostic score for the selection of patients for salvage surgery after recurrent head and neck squamous cell carcinomas.
Lupato V; Polesel J; La Torre FB; Fanetti G; Fratta E; Gobitti C; Baldassarre G; Vaccher E; Franchin G; Giacomarra V
Sci Rep; 2021 Jan; 11(1):502. PubMed ID: 33436706
[TBL] [Abstract][Full Text] [Related]
20. Treatment Package Time in Node-Positive Cutaneous Head and Neck Squamous Cell Carcinoma.
Daniels CP; Bressel M; Corry J; Cole A; Chua MS; Tiong A; Hirshoren N; Dixon B; McDowell L
Pract Radiat Oncol; 2020; 10(1):29-35. PubMed ID: 31606546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
